Inflammatory Bowel Disease

The ACG’s treatment guidelines for Crohn disease offer significant lessons for physicians. David A. Schwartz, MD, provided an overview at the Advances in Inflammatory Bowel Disease virtual regional meeting...

Biosimilars show promise in reducing costs and equaling efficacy, compared with originator compounds. But will they live up to that potential? Russell Cohen, MD, addressed these issues and more at the...

What exactly is precision medicine, and is it ready to be applied in gastroenterology practice? Millie Long, MD, discussed the topic at the virtual Advances in Inflammatory Bowel Disease regional meeting on...

Applying a systematic treat-to-target approach is effective for reducing the risk of long-term complications in patients with IBD, but incremental benefit must be evaluated. Siddarth Singh, MD, spoke about...

In her session, Millie Long, MD, reviewed the role of anticytokine therapy for treating Crohn disease and how new approaches to diagnosing, monitoring, and treating Crohn disease have helped advance the...

The many different classes of medications available for treating inflammatory bowel disease give gastroenterologists more options than ever before—and also more challenges in determining how to balance...

The treatment of inflammatory bowel disease has changed dramatically since the introduction of biologics and small molecule therapeutics. But does that mean older therapies no longer have any role? David...

Some patients with IBD require surgery to improve symptoms and quality of life. Joel Goldberg, MD, explained how to help patients prepare for surgery and achieve optimum recovery at the Advances in...